Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 31 Issue 1
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2013  >  31(1): 19-21

ZHAO Xin-bin, NI Min, TAO Xia. Progress on the multiple pharmacological activity and mechanism of statins[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(1): 19-21. doi: 10.3969/j.issn.1006-0111.2013.01.005
Citation: ZHAO Xin-bin, NI Min, TAO Xia. Progress on the multiple pharmacological activity and mechanism of statins[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(1): 19-21. doi: 10.3969/j.issn.1006-0111.2013.01.005
shu

Progress on the multiple pharmacological activity and mechanism of statins

doi: 10.3969/j.issn.1006-0111.2013.01.005

  • Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China

  • Received Date: 2012-02-14
  • Rev Recd Date: 2012-04-05
  • Statins were a mainstay in the treatment of hyperlipidemia and used in the primary and secondary prevention of coronary artery disease. Recent studies indicated that there were some cholesterol-independent or pleiotropic effects of statins, including improving endothelial function, decreasing oxidative stress, inhibiting inflammation, enhancing the stability of atherosclerotic plaques and used for anticancer therapy. The effects and mechanisms of statins on vascular disease and cancer were reviewed in this paper.
  • [1] Liao JK, Laufs U. Pleiotropic effects of stains[J]. Annu Rev Pharmacol Toxicol, 2005,45:89.
    [2] Farwell WR,D'Avolio LW,Scranton RE,et al. Stains and prostate cancer diagnosis and grade in a veterans population[J].J Natl Cancer Inst, 2011, 103(11):885.
    [3] Vaughan CJ, Gotto AM. Update on statins: 2003[J].Circulation, 2004, 110:886.
    [4] Alonso R,Mata P. Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin[J].Atherosclerosis,2001, 157:423.
    [5] Tsunekawa T,Hayashi T. Cerivastain,a hydroxymethylglutaryl coenzyme reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days[J].Circulation, 2001, 104:376.
    [6] Williams JK, Sukhova GK, Herring DM, et al. Pravastain has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[J].J Am CollCardoil, 1998, 31:684.
    [7] Endres M, Laufs U. Effects of statins on endothelium and signaling mechanisms[J].Stroke, 2004, 35:2708.
    [8] Walter DH, Zeiher AM, Dimmeler S. Effects of statins on endothelim and their contribution to neovascularization by mobilization of endothelil progenitor cells[J].Coronary Artery Disease, 2004, 15:235.
    [9] 陈巧玲,蔡宝祥.他汀类药物防治动脉粥样硬化作用研究进展[J].药学实践杂志,2006,24(6):321.
    [10] Assmus B, Urbich C, Aicher A, et al. HMG-CoA Reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes[J].Circulation Res, 2003, 92:1049.
    [11] Vasa M, Fichtlscherer S. Increase in circulating endotheliap progenitor cells by stain therapy in patients with stable coronary artery disease[J].Circulation, 2001, 103:2885.
    [12] Fukumoto Y, Libby P, Rabkin E, et al. Stains alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits[J].Circulation, 2001, 103:993.
    [13] Vincent L, Chen W, Hong L, et al. Inhibition of endothelial cell migration by cerivastation, an HMG-CoA reductase inhibitor:contribution to its anti-angiogenic effect[J].FEBS Lett, 2001, 495(3):159.
    [14] Yamakawa T,Tanaka S,Kamei J,et al. Pitavsatatin inhibits vascular Smooth muscle cell proliferation by inactivating extracellular signal-regulated kinase 1/2[J].J Atheroscler Thromb,2003,10(1):37.
    [15] Richard K. The Jupiter study, CRP screening, and aggressive statin therapy implications for the primary prevention of cardiovascular disease[J].Ther Adv Cardiovasc Dis, 2009,3(4):309.
    [16] 李秋荣,王 勤,曲 环,等.瑞舒伐他汀对血脂正常的2型糖尿病患者血清高敏C 反应蛋白的作用[J].中华高血压杂志,2011,19(3):280.
    [17] Bonetti PO, Lerman LO, et al. Stain effects beyond lipid lowering-are they clinically relevant?[J].European Heart Journal, 2003, 24(3):225.
    [18] Giannotti G,Landmesser U. Endothelial dysfunction as an early sign of atherosclerosis[J].Herz, 2007, 32(7):568.
    [19] 陈 瑗,周 玫.氧化应激-炎症在动脉粥样硬化发生发展中作用研究的新进展[J].中国动脉硬化杂志,2008, 16(10):757.
    [20] Hawk E, Viner JL. Statins and cancer—beyond the “one drug, one disease” model[J].N Engl J Med, 2005, 352(21):2184.
    [21] 王 磊,胡昌华.他汀类药物抗癌作用新机制[J].中国药学杂志,2010,45(23):1796.
    [22] Sassano A,Katsoulidis E,Antico G,et al. Suppressive effects of statins on actue promyelocytic leukemia cells[J].Cancer Res,2007, 67(9)4524.
    [23] Weis M,Heeschen C,Glassford AJ,et al. Statins have biphasic effects on angiogenesis[J].Circulation,2002, 105:739.
    [24] Fromigué O, Hamidouche Z, Marie PJ. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion[J]. J Biol Chem,2008, 284(45):30549.
    [25] Cho SJ, Kim JS, Kim JM, et al. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts,and attenuates colitisassociated colon cancer in mice[J]. Int J Cancer, 2008, 123:951.
    [26] 李 颖,张增叶,姜 达.洛伐他汀对恶性黑色素瘤B16细胞株的作用及其机制的研究[J]. 实用肿瘤学杂志,2008,6:520.
    [27] 江庭秀,顾伟英,邱国强,等.辛伐他汀联合阿糖胞苷对K562细胞增殖与凋亡的影响[J].白血病·淋巴瘤,2011,20(1):35.
    [28] 张 莉.他汀类药物调脂及非调脂作用的临床新进展[J].医学信息,2011,24(7):4248.
    [29] Khurana V,Beijjanki HR,Caldito G,et al. Statins reduce the risk of lung cancer in humans,a large case-control study of US veterans[J]. Chest,2007, 131(5):1282.
    [30] 吴苏舒,刘玉明,陈 静.他汀类药物调脂外临床应用概况[J].药学实践杂志,2007,25(1):4.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(3906) PDF downloads(421) Cited by()

Related
Proportional views

Progress on the multiple pharmacological activity and mechanism of statins

doi: 10.3969/j.issn.1006-0111.2013.01.005
  • Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
  • Received Date: 2012-02-14
  • Rev Recd Date: 2012-04-05

Abstract: Statins were a mainstay in the treatment of hyperlipidemia and used in the primary and secondary prevention of coronary artery disease. Recent studies indicated that there were some cholesterol-independent or pleiotropic effects of statins, including improving endothelial function, decreasing oxidative stress, inhibiting inflammation, enhancing the stability of atherosclerotic plaques and used for anticancer therapy. The effects and mechanisms of statins on vascular disease and cancer were reviewed in this paper.

ZHAO Xin-bin, NI Min, TAO Xia. Progress on the multiple pharmacological activity and mechanism of statins[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(1): 19-21. doi: 10.3969/j.issn.1006-0111.2013.01.005
Citation: ZHAO Xin-bin, NI Min, TAO Xia. Progress on the multiple pharmacological activity and mechanism of statins[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(1): 19-21. doi: 10.3969/j.issn.1006-0111.2013.01.005
shu

    HTML

Reference (30)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return